Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach-Reference-Cited by-同舟云学术

Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach

Published:2017-05-09 Issue:14 Volume:174 Page:2209-2224
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Ryan Ali¹^ORCID,Polycarpou Elena¹,Lack Nathan A²³,Evangelopoulos Dimitrios⁴⁵⁶^ORCID,Sieg Christian¹,Halman Alice¹,Bhakta Sanjib⁴,Eleftheriadou Olga¹,McHugh Timothy D⁵^ORCID,Keany Sebastian²,Lowe Edward D⁷,Ballet Romain²,Abuhammad Areej⁸,Jacobs William R⁹,Ciulli Alessio¹⁰¹¹^ORCID,Sim Edith¹²^ORCID

Affiliation:

1. Faculty of Science, Engineering and Computing; Kingston University London; Kingston upon Thames UK

2. Department of Pharmacology; University of Oxford; Oxford UK

3. School of Medicine; Koç University; Istanbul Turkey

4. Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Sciences; Birkbeck, University of London; London UK

5. Centre for Clinical Microbiology; University College London, Royal Free Campus; London UK

6. Mycobacterial Metabolism and Antibiotic Research Laboratory; The Francis Crick Institute, Mill Hill Laboratory; London UK

7. Department of Biochemistry; University of Oxford; Oxford UK

8. School of Pharmacy; University of Jordan; Amman Jordan

9. Department of Microbiology and Immunology; Howard Hughes Medical Institute, Albert Einstein College of Medicine; Bronx New York USA

10. Department of Chemistry; University of Cambridge; Cambridge UK

11. Division of Biological Chemistry & Drug Discovery, School of Life Sciences; University of Dundee, James Black Centre; Dundee UK

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13810/fullpdf

Reference65 articles.

1. PHENIX: a comprehensive Python-based system for macromolecular structure solution;Adams;Acta Crystallogr D,2010

2. Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG;Anderton;Mol Microbiol,2006

3. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M bovis BCG and M smegmatis;Bardarov;Microbiology,2002

4. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target;Bhakta;J Exp Med,2004

5. Differential transcriptome profiles of attenuated and hypervirulent strains of Mycobacterium bovis;Blanco;Microbes Infect,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arylamine N-Acetyltransferases;Reference Module in Biomedical Sciences;2024

2. FBDD & De Novo Drug Design;Applied Computer-Aided Drug Design: Models and Methods;2023-12-07

3. Recent advances in Fragment-based strategies against tuberculosis;European Journal of Medicinal Chemistry;2023-10

4. Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis;The FEBS Journal;2022-10-13

5. The unusual convergence of steroid catabolic pathways in Mycobacterium abscessus;Proceedings of the National Academy of Sciences;2022-09-26